Pub Date : 2022-03-20DOI: 10.20471/may.2022.58.01.03
A. Obadeji, Peter Olufemi Areo, Patrick Temi Adegun
- Background: Depression among the elderly presents with an increased risk of morbidity, impaired physical, cognitive and social functioning, with a negative influence on the prognosis of other chronic diseases. The study was aimed at examining the burden of depression and its relationship with prostatic symptoms among patients with benign prostatic hyperplasia (BPH). Methods: Participants were evaluated with the Geriatric Depression Scale (GDS) and the International Prostate Symptom Score (IPSS). Association between depression and socio-demographic variables was assessed using multiple logistic regression, and between GDS scores, IPSS, and the duration of lower urinary tract symptoms (LUTS) using Spearman’s correlation. Results: Of the population studied, 41.1% had significant depressive symptoms. Participants aged 65years and above AOR=1.78, (95% CI=0.61-5.16), secondary education and below AOR =3.63, (95% CI= 1.37- 9.63), p= 0.01, Unemployed AOR=1.99, (95% CI=0.77-5.13), or had Comorbid illness AOR=2.28, (95% CI=0.97-5.34), p= 0.06 were more likely to be depressed. There was positive correlation between GDS scores and IPSS scores (r=0.385, p=0.001), duration of LUTs (r=0.238, p=0.009) and quality of life (QoL) (r=0.227, p=0.013), and between IPSS scores and (QoL) (r=0.348, p=0.001). Conclusion: A higher proportion of participants had significant depressive symptoms, the risk of which is increased by both clinical and socio-demographic variables.
{"title":"Association between Significant Depressive Symptoms and Prostatic Symptoms among Patients with Benign Prostatic Hyperplasia","authors":"A. Obadeji, Peter Olufemi Areo, Patrick Temi Adegun","doi":"10.20471/may.2022.58.01.03","DOIUrl":"https://doi.org/10.20471/may.2022.58.01.03","url":null,"abstract":"- Background: Depression among the elderly presents with an increased risk of morbidity, impaired physical, cognitive and social functioning, with a negative influence on the prognosis of other chronic diseases. The study was aimed at examining the burden of depression and its relationship with prostatic symptoms among patients with benign prostatic hyperplasia (BPH). Methods: Participants were evaluated with the Geriatric Depression Scale (GDS) and the International Prostate Symptom Score (IPSS). Association between depression and socio-demographic variables was assessed using multiple logistic regression, and between GDS scores, IPSS, and the duration of lower urinary tract symptoms (LUTS) using Spearman’s correlation. Results: Of the population studied, 41.1% had significant depressive symptoms. Participants aged 65years and above AOR=1.78, (95% CI=0.61-5.16), secondary education and below AOR =3.63, (95% CI= 1.37- 9.63), p= 0.01, Unemployed AOR=1.99, (95% CI=0.77-5.13), or had Comorbid illness AOR=2.28, (95% CI=0.97-5.34), p= 0.06 were more likely to be depressed. There was positive correlation between GDS scores and IPSS scores (r=0.385, p=0.001), duration of LUTs (r=0.238, p=0.009) and quality of life (QoL) (r=0.227, p=0.013), and between IPSS scores and (QoL) (r=0.348, p=0.001). Conclusion: A higher proportion of participants had significant depressive symptoms, the risk of which is increased by both clinical and socio-demographic variables.","PeriodicalId":8294,"journal":{"name":"Archives of Psychiatry Research","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42290467","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-03-20DOI: 10.20471/may.2022.58.01.05
M. Vučić Peitl, Marica Čargonja, Fadil Habibović, Bernard Šešo
- Healthcare decisions may have life-changing consequences which are even more important in schizophrenia treatment programs. In this study, we hypothesized that there is a significant difference in treatment satisfaction among patients after completing the one-year psychoeducation program. We expected a higher overall treatment satisfaction among 19 schizophrenic patients on olanzapine long acting injection after completing the one-year psychoeducation program. Results showed that there is no difference in treatment satisfaction among patients after completing the psychoeducational program. However, the additional analysis did elicit a statistically significant change in treatment satisfaction before and after enrolling in the olanzapine long acting program. Patients reported a significantly higher treatment satisfaction after enrolling in the olanzapine long acting injection program than before, previous to completing the psychoeducational program, as well as after the program completion. We concluded that the patient’s treatment satisfaction with the psychoeducative program achieved a constant high value even after a year of enrolling. A high treatment satisfaction shows that this type of therapy has a great potential in providing a more successful positive outcome in the treatment of schizophrenic patients, and it should be considered as a crucial part of patient care and treatment.
{"title":"Effects of Psychoeducation on Treatment Satisfaction in Schizophrenic Patients on Olanzapine Long Acting Injection","authors":"M. Vučić Peitl, Marica Čargonja, Fadil Habibović, Bernard Šešo","doi":"10.20471/may.2022.58.01.05","DOIUrl":"https://doi.org/10.20471/may.2022.58.01.05","url":null,"abstract":"- Healthcare decisions may have life-changing consequences which are even more important in schizophrenia treatment programs. In this study, we hypothesized that there is a significant difference in treatment satisfaction among patients after completing the one-year psychoeducation program. We expected a higher overall treatment satisfaction among 19 schizophrenic patients on olanzapine long acting injection after completing the one-year psychoeducation program. Results showed that there is no difference in treatment satisfaction among patients after completing the psychoeducational program. However, the additional analysis did elicit a statistically significant change in treatment satisfaction before and after enrolling in the olanzapine long acting program. Patients reported a significantly higher treatment satisfaction after enrolling in the olanzapine long acting injection program than before, previous to completing the psychoeducational program, as well as after the program completion. We concluded that the patient’s treatment satisfaction with the psychoeducative program achieved a constant high value even after a year of enrolling. A high treatment satisfaction shows that this type of therapy has a great potential in providing a more successful positive outcome in the treatment of schizophrenic patients, and it should be considered as a crucial part of patient care and treatment.","PeriodicalId":8294,"journal":{"name":"Archives of Psychiatry Research","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41945906","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-03-20DOI: 10.20471/may.2022.58.01.12
Pejman Abbasi Pashaki, Kiarash Shirbandi, Sina Ramezani, F. Rahim, Z. Jamalpoor
Today, a new coronavirus (2019-nCoV, later named SARS-CoV-2) has become known as a pandemic with over 3,949,200 cases and 271,782 deaths. It has been considered that most of the deaths in infected patients stem from co-morbidity conditions. Therefore, understanding at-risk populations are currently under the focus of investigations. This object has highly driven attention to put patients with a higher potential of death related to SARS-CoV2 infection at priority. For instance, this can happen in Schizophrenia owing to ambiguous immunology attributes, including elevated levels of pro-inflammatory cytokines and stress-related immune disability. Given that, the hyper-inflammatory responses are the significant cause of the pathophysiology of the SARS-CoV2-related mortality. Moreover, SARS-CoV2 can prompt the risk of developing Schizophrenia in the future. This review punctuates that prenatal/perinatal infection could be associated with increased Schizophrenia risk;on the flip side, the potential risk of ongoing medication can worsen mentally disabled patients, and healthy people are at risk.
{"title":"SARS-Cov2-Induced Cytokine Storm and Schizophrenia, Could There be a Connection?","authors":"Pejman Abbasi Pashaki, Kiarash Shirbandi, Sina Ramezani, F. Rahim, Z. Jamalpoor","doi":"10.20471/may.2022.58.01.12","DOIUrl":"https://doi.org/10.20471/may.2022.58.01.12","url":null,"abstract":"Today, a new coronavirus (2019-nCoV, later named SARS-CoV-2) has become known as a pandemic with over 3,949,200 cases and 271,782 deaths. It has been considered that most of the deaths in infected patients stem from co-morbidity conditions. Therefore, understanding at-risk populations are currently under the focus of investigations. This object has highly driven attention to put patients with a higher potential of death related to SARS-CoV2 infection at priority. For instance, this can happen in Schizophrenia owing to ambiguous immunology attributes, including elevated levels of pro-inflammatory cytokines and stress-related immune disability. Given that, the hyper-inflammatory responses are the significant cause of the pathophysiology of the SARS-CoV2-related mortality. Moreover, SARS-CoV2 can prompt the risk of developing Schizophrenia in the future. This review punctuates that prenatal/perinatal infection could be associated with increased Schizophrenia risk;on the flip side, the potential risk of ongoing medication can worsen mentally disabled patients, and healthy people are at risk.","PeriodicalId":8294,"journal":{"name":"Archives of Psychiatry Research","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46628867","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-03-20DOI: 10.20471/may.2022.58.01.02
Reem Hassan Elghamry, A. Saad Mohammed, Doa Mohammed Ali, Yomna El Hawary
- Aim: The study is one of only few studies that was concerned with effect of atypical antipsychotics on serum Brain-Derived Neutorophic Factor (BDNF) level, as well as the relation between serum BDNF level and severity of symp -toms. Methods: This was a prospective study conducted on 45 patients with first episode schizophrenia, patients were diagnosed by Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I), severity of symptoms assessed by PANSS (Positive And Negative Syndrome) scale, serum level of BDNF was assessed in all patients before starting their medication and after 6 weeks of receiving atypical antipsychotic. Results: Serum BDNF levels were decreased after 6 weeks of treat ment with atypical antipsychotic in patients with first episode schizophrenia, risperidone and quetiapine showed statisti cally significant decrease (p values 0.004, 0.041 respectively) in BDNF level after 6 weeks of therapy. PANSS score was decreased after 6 weeks of treatment with atypical antipsychotic in patients with first episode schizophrenia. Quetiapine showed the highest mean difference 65.4 ± 13.5 and the amisulpride showed the least mean difference 43.7 ± 4.9. There was no significant correlation between serum BDNF level and severity of the symptoms (p value 0.328), while we estab lished a negative correlation between BDNF level and negative symptoms (r = -0.321). We did not establish significant differences (p value = 0.604) between subtypes of schizophrenia regarding BDNF level. Conclusions: Further cognitive, neuropsychological and psychopathological assessment could be useful to clarify the involvement of BDNF in the endopheno typic characteristics of schizophrenia.
-目的:本研究是为数不多的研究非典型抗精神病药物对血清脑源性中性营养因子(BDNF)水平的影响以及血清BDNF水平与症状严重程度的关系的研究之一。方法:对45例首发精神分裂症患者进行前瞻性研究，采用DSM-IV - Axis I Disorders (SCID-I)结构化临床访谈法对患者进行诊断，采用PANSS (Positive And Negative Syndrome，阳性与阴性综合征)量表评估患者症状严重程度，在患者开始用药前及接受非典型抗精神病药6周后评估患者血清BDNF水平。结果:首发精神分裂症患者非典型抗精神病药治疗6周后血清BDNF水平下降，利培酮和喹硫平治疗6周后BDNF水平下降有统计学意义(p值分别为0.004、0.041)。首发精神分裂症患者非典型抗精神病药治疗6周后PANSS评分下降。喹硫平的平均差异最大(65.4±13.5)，氨硫pride的平均差异最小(43.7±4.9)。血清BDNF水平与症状严重程度无显著相关(p值0.328)，而BDNF水平与阴性症状呈负相关(r = -0.321)。我们没有发现精神分裂症亚型之间关于BDNF水平的显著差异(p值= 0.604)。结论:进一步的认知、神经心理学和精神病理学评估可能有助于阐明BDNF在精神分裂症内表型特征中的作用。
{"title":"Effect of Atypical Antipsychotics on Serum BDNF in an Egyptian First Samples of First Episode Schizophrenia Patients","authors":"Reem Hassan Elghamry, A. Saad Mohammed, Doa Mohammed Ali, Yomna El Hawary","doi":"10.20471/may.2022.58.01.02","DOIUrl":"https://doi.org/10.20471/may.2022.58.01.02","url":null,"abstract":"- Aim: The study is one of only few studies that was concerned with effect of atypical antipsychotics on serum Brain-Derived Neutorophic Factor (BDNF) level, as well as the relation between serum BDNF level and severity of symp -toms. Methods: This was a prospective study conducted on 45 patients with first episode schizophrenia, patients were diagnosed by Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I), severity of symptoms assessed by PANSS (Positive And Negative Syndrome) scale, serum level of BDNF was assessed in all patients before starting their medication and after 6 weeks of receiving atypical antipsychotic. Results: Serum BDNF levels were decreased after 6 weeks of treat ment with atypical antipsychotic in patients with first episode schizophrenia, risperidone and quetiapine showed statisti cally significant decrease (p values 0.004, 0.041 respectively) in BDNF level after 6 weeks of therapy. PANSS score was decreased after 6 weeks of treatment with atypical antipsychotic in patients with first episode schizophrenia. Quetiapine showed the highest mean difference 65.4 ± 13.5 and the amisulpride showed the least mean difference 43.7 ± 4.9. There was no significant correlation between serum BDNF level and severity of the symptoms (p value 0.328), while we estab lished a negative correlation between BDNF level and negative symptoms (r = -0.321). We did not establish significant differences (p value = 0.604) between subtypes of schizophrenia regarding BDNF level. Conclusions: Further cognitive, neuropsychological and psychopathological assessment could be useful to clarify the involvement of BDNF in the endopheno typic characteristics of schizophrenia.","PeriodicalId":8294,"journal":{"name":"Archives of Psychiatry Research","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41788852","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-03-20DOI: 10.20471/may.2022.58.01.14
V. Peitl, D. Vlahović
Schizophrenia is a severe, chronic, and often disabling psychiatric disorder affecting nearly 20 million people worldwide [1]. Schizophrenia persists to be one of the hardest diseases to treat nowadays. Reasons can be found in the heterogeneity within the disease and regards to the treatment response. In general, the first episode occurs in late adolescence and is usually foregone by a prodromal phase characterized by social and cognitive deficits. Positive symptoms tend to appear in a relapsingremitting fashion, while cognitive and negative symptomatology has a more chronic trajectory and impacts social functioning [2]. Despite the complexity of the disease, current pharmacological treatment primarily relies on dopamine receptor (D2) blockade. First generation antipsychotics predominantly deploy their action through D2 receptor blockade. Second-generation antipsychotics exert additional antagonism at other receptors such as those of the serotonin system, such as 5-HT2A. Several antipsychotics also demonstrate additional activity at adrenergic, cholinergic, histaminergic and other serotonergic reTrace amine-associated receptor 1 (TAAR1) agonists
{"title":"Trace amine-associated receptor 1 (TAAR1) agonists","authors":"V. Peitl, D. Vlahović","doi":"10.20471/may.2022.58.01.14","DOIUrl":"https://doi.org/10.20471/may.2022.58.01.14","url":null,"abstract":"Schizophrenia is a severe, chronic, and often disabling psychiatric disorder affecting nearly 20 million people worldwide [1]. Schizophrenia persists to be one of the hardest diseases to treat nowadays. Reasons can be found in the heterogeneity within the disease and regards to the treatment response. In general, the first episode occurs in late adolescence and is usually foregone by a prodromal phase characterized by social and cognitive deficits. Positive symptoms tend to appear in a relapsingremitting fashion, while cognitive and negative symptomatology has a more chronic trajectory and impacts social functioning [2]. Despite the complexity of the disease, current pharmacological treatment primarily relies on dopamine receptor (D2) blockade. First generation antipsychotics predominantly deploy their action through D2 receptor blockade. Second-generation antipsychotics exert additional antagonism at other receptors such as those of the serotonin system, such as 5-HT2A. Several antipsychotics also demonstrate additional activity at adrenergic, cholinergic, histaminergic and other serotonergic reTrace amine-associated receptor 1 (TAAR1) agonists","PeriodicalId":8294,"journal":{"name":"Archives of Psychiatry Research","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48922116","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-03-20DOI: 10.20471/may.2022.58.01.11
E. Brezovec, Z. Zoričić, T. Glavina
COVID-19 has changed the social context, but also our ability to act in it. This new normal also influenced the patterns of alcohol consumption. In this sense, the main goal of this paper is a theoretical analysis of COVID-19 context of sociability of alcohol consumption. The paper analyses the ways of establishing the individual meaningfulness of alcohol consumption. The stratification of collective patterns in the context of a pandemic is analysed and the implications of stratification on future drinking patterns, but also on the potential risks of higher alcoholism rates in the future are theo-retically considered. The analysis is based on previous research on the habits of alcohol consumption during quarantine. The rate of alcohol consumption in the studies did not differ significantly from that before quarantine. In some cases, a lower rate of alcohol consumption has been reported. However, the rate of excessive drinking, and socially unregulated drinking, individual drinking, and drinking of a larger number of alcoholic beverages on occasion was on the rise. The theoretical explanation that can be set on the basis of previous research supports the fact that society is responsible for regulating the acceptable alcohol consumption. In the absence of social/cultural influences, an individual consumes alcohol for his own pleasure-it is directed towards himself and not towards society. If this social and value meaningfulness of alcohol consumption is lost, the individual will have a higher risk of developing alcohol dependence. Society is a protec-tive factor in the development of alcohol dependence. During the COVID-19 pandemic, most individuals did not consume alcohol because of the social patterns that that consumption implies (or is an integral part of), but they consumed it because of internal anxiety. The use of alcohol for the purpose of calming the anxiety caused by the pandemic, without an individual reflection on the sociability of alcohol consumption, is a potential public health problem of the future.
{"title":"Sociability of Alcohol Consumption and Alcoholism in Times of COVID-19 Crisis","authors":"E. Brezovec, Z. Zoričić, T. Glavina","doi":"10.20471/may.2022.58.01.11","DOIUrl":"https://doi.org/10.20471/may.2022.58.01.11","url":null,"abstract":"COVID-19 has changed the social context, but also our ability to act in it. This new normal also influenced the patterns of alcohol consumption. In this sense, the main goal of this paper is a theoretical analysis of COVID-19 context of sociability of alcohol consumption. The paper analyses the ways of establishing the individual meaningfulness of alcohol consumption. The stratification of collective patterns in the context of a pandemic is analysed and the implications of stratification on future drinking patterns, but also on the potential risks of higher alcoholism rates in the future are theo-retically considered. The analysis is based on previous research on the habits of alcohol consumption during quarantine. The rate of alcohol consumption in the studies did not differ significantly from that before quarantine. In some cases, a lower rate of alcohol consumption has been reported. However, the rate of excessive drinking, and socially unregulated drinking, individual drinking, and drinking of a larger number of alcoholic beverages on occasion was on the rise. The theoretical explanation that can be set on the basis of previous research supports the fact that society is responsible for regulating the acceptable alcohol consumption. In the absence of social/cultural influences, an individual consumes alcohol for his own pleasure-it is directed towards himself and not towards society. If this social and value meaningfulness of alcohol consumption is lost, the individual will have a higher risk of developing alcohol dependence. Society is a protec-tive factor in the development of alcohol dependence. During the COVID-19 pandemic, most individuals did not consume alcohol because of the social patterns that that consumption implies (or is an integral part of), but they consumed it because of internal anxiety. The use of alcohol for the purpose of calming the anxiety caused by the pandemic, without an individual reflection on the sociability of alcohol consumption, is a potential public health problem of the future.","PeriodicalId":8294,"journal":{"name":"Archives of Psychiatry Research","volume":"617 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41283368","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-03-20DOI: 10.20471/may.2022.58.01.13
O. Banyra, Oxana Jourkiv, Oleg Nikitin, I. Ventskivska, Zvenyslava Kechur, Viacheslav L Didkovskiy
Oleg Banyra1,2, Oxana Jourkiv3, Oleg Nikitin4, Iryna Ventskivska5, Zvenyslava Kechur6, Viacheslav Didkovskiy7 1Department of Urology, St. Paraskeva Medical Centre, Lviv, Ukraine, 2Department of Surgery, 2nd Lviv Municipal Polyclinic, Lviv, Ukraine, 3Child and Family Counseling Group, P.L.C., Fairfax, VA, United States of America, 4Department of Urology, Bogomolets National Medical University, Kyiv, Ukraine, 5Department of Gynecology, Bogomolets National Medical University, Kyiv, Ukraine, 6Psychiatrist, Psychotherapeutist, St. Paraskeva Medical Centre, Lviv, Ukraine, 7Department of Otorhinolaryngology, Bogomolets National Medical University, Kyiv, Ukraine Case report
{"title":"Misophonia in Urological Patients: Our Experience of Management","authors":"O. Banyra, Oxana Jourkiv, Oleg Nikitin, I. Ventskivska, Zvenyslava Kechur, Viacheslav L Didkovskiy","doi":"10.20471/may.2022.58.01.13","DOIUrl":"https://doi.org/10.20471/may.2022.58.01.13","url":null,"abstract":"Oleg Banyra1,2, Oxana Jourkiv3, Oleg Nikitin4, Iryna Ventskivska5, Zvenyslava Kechur6, Viacheslav Didkovskiy7 1Department of Urology, St. Paraskeva Medical Centre, Lviv, Ukraine, 2Department of Surgery, 2nd Lviv Municipal Polyclinic, Lviv, Ukraine, 3Child and Family Counseling Group, P.L.C., Fairfax, VA, United States of America, 4Department of Urology, Bogomolets National Medical University, Kyiv, Ukraine, 5Department of Gynecology, Bogomolets National Medical University, Kyiv, Ukraine, 6Psychiatrist, Psychotherapeutist, St. Paraskeva Medical Centre, Lviv, Ukraine, 7Department of Otorhinolaryngology, Bogomolets National Medical University, Kyiv, Ukraine Case report","PeriodicalId":8294,"journal":{"name":"Archives of Psychiatry Research","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43161368","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-03-20DOI: 10.20471/may.2022.58.01.10
S. Nadalin, V. Peitl, D. Karlović, Sanja Dević Pavlić, Mislav Škrobo, Melita Uremović, Lena Zatković, A. Buretić-Tomljanović
Sergej Nadalin1, Vjekoslav Peitl2,3, Dalibor Karlović2,3, Sanja Dević Pavlić4, Mislav Škrobo2, Melita Uremović3, Lena Zatković5, Alena Buretić-Tomljanović4 1Department of Psychiatry, General Hospital “Dr. Josip Benčević”, Slavonski Brod, Croatia, 2Department of Psychiatry, University Hospital Center Sestre Milosrdnice, Zagreb, Croatia, 3School of Medicine, Catholic University of Croatia, Zagreb, Croatia, 4Department of Medical Biology and Genetics, Faculty of Medicine, University of Rijeka, Rijeka, Croatia, 5Hospital Pharmacy, Clinical Hospital Center Rijeka, Rijeka, Croatia Original paper
{"title":"Could the Type of Delivery Contribute to Clinical Features of Schizophrenia and Nicotine Dependence among Patients Who are not Under Antipsychotic Treatment?","authors":"S. Nadalin, V. Peitl, D. Karlović, Sanja Dević Pavlić, Mislav Škrobo, Melita Uremović, Lena Zatković, A. Buretić-Tomljanović","doi":"10.20471/may.2022.58.01.10","DOIUrl":"https://doi.org/10.20471/may.2022.58.01.10","url":null,"abstract":"Sergej Nadalin1, Vjekoslav Peitl2,3, Dalibor Karlović2,3, Sanja Dević Pavlić4, Mislav Škrobo2, Melita Uremović3, Lena Zatković5, Alena Buretić-Tomljanović4 1Department of Psychiatry, General Hospital “Dr. Josip Benčević”, Slavonski Brod, Croatia, 2Department of Psychiatry, University Hospital Center Sestre Milosrdnice, Zagreb, Croatia, 3School of Medicine, Catholic University of Croatia, Zagreb, Croatia, 4Department of Medical Biology and Genetics, Faculty of Medicine, University of Rijeka, Rijeka, Croatia, 5Hospital Pharmacy, Clinical Hospital Center Rijeka, Rijeka, Croatia Original paper","PeriodicalId":8294,"journal":{"name":"Archives of Psychiatry Research","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48732748","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：